201 related articles for article (PubMed ID: 38664528)
1. Urinary metabolomic profiling of a cohort of Colombian patients with systemic lupus erythematosus.
Rojo-Sánchez A; Carmona-Martes A; Díaz-Olmos Y; Santamaría-Torres M; Cala MP; Orozco-Acosta E; Aroca-Martínez G; Pacheco-Londoño L; Navarro-Quiroz E; Pacheco-Lugo LA
Sci Rep; 2024 Apr; 14(1):9555. PubMed ID: 38664528
[TBL] [Abstract][Full Text] [Related]
2. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
[TBL] [Abstract][Full Text] [Related]
3. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
4. Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry.
Yan B; Huang J; Dong F; Yang L; Huang C; Gao M; Shi A; Zha W; Shi L; Hu X
Biomed Chromatogr; 2016 Nov; 30(11):1877-1881. PubMed ID: 27061577
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.
Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR
J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus.
Zhang Y; Gan L; Tang J; Liu D; Chen G; Xu B
Front Immunol; 2022; 13():967371. PubMed ID: 36059469
[TBL] [Abstract][Full Text] [Related]
7. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
[TBL] [Abstract][Full Text] [Related]
8. NMR-Based Serum Metabolomics Reveals Reprogramming of Lipid Dysregulation Following Cyclophosphamide-Based Induction Therapy in Lupus Nephritis.
Guleria A; Phatak S; Dubey D; Kumar S; Zanwar A; Chaurasia S; Kumar U; Gupta R; Aggarwal A; Kumar D; Misra R
J Proteome Res; 2018 Jul; 17(7):2440-2448. PubMed ID: 29877087
[TBL] [Abstract][Full Text] [Related]
9. Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis.
Olivares D; Perez-Hernandez J; Forner MJ; Perez-Soriano C; Tormos MC; Saez GT; Chaves FJ; Redon J; Cortes R
Clin Sci (Lond); 2018 Mar; 132(5):569-579. PubMed ID: 29440621
[TBL] [Abstract][Full Text] [Related]
10. Fecal Metabolites Were Altered, Identified as Biomarkers and Correlated With Disease Activity in Patients With Systemic Lupus Erythematosus in a GC-MS-Based Metabolomics Study.
Yan R; Jiang H; Gu S; Feng N; Zhang N; Lv L; Liu F
Front Immunol; 2020; 11():2138. PubMed ID: 33013903
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response.
Kim JW; Baek WY; Jung JY; Kim HA; Lee SW; Suh CH
Front Immunol; 2024; 15():1369385. PubMed ID: 38915417
[TBL] [Abstract][Full Text] [Related]
12. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
[TBL] [Abstract][Full Text] [Related]
13. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
14. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
[TBL] [Abstract][Full Text] [Related]
15. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
16. Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis.
Chen S; Zhang X; Meng K; Sun Y; Shu R; Han Y; Feng Q; Li Z; Yang P; Liang J
Front Immunol; 2023; 14():1077645. PubMed ID: 36845141
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling reveals new serum biomarkers of lupus nephritis.
Li J; Xie XW; Zhou H; Wang B; Zhang MJ; Tang FY
Lupus; 2017 Oct; 26(11):1166-1173. PubMed ID: 28420061
[TBL] [Abstract][Full Text] [Related]
18. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
19. Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis.
Ganguly S; Kumar U; Gupta N; Guleria A; Majumdar S; Phatak S; Chaurasia S; Kumar S; Aggarwal A; Kumar D; Misra R
Lupus; 2020 Jun; 29(7):782-786. PubMed ID: 32299281
[TBL] [Abstract][Full Text] [Related]
20. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis.
Pitashny M; Schwartz N; Qing X; Hojaili B; Aranow C; Mackay M; Putterman C
Arthritis Rheum; 2007 Jun; 56(6):1894-903. PubMed ID: 17530720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
